|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.66 USD | +5.73% |
|
+11.52% | +3.11% |
| May. 14 | Earnings Flash (DYAI) DYADIC INTERNATIONAL Posts Q1 Revenue $334.6M | MT |
| Mar. 28 | Transcript : Dyadic International, Inc., 2023 Earnings Call, Mar 28, 2024 |
Dyadic International, Inc. appointed Jack Kaye to the Board of Directors, effective April 1, 2015. Mr. Kaye will serve on the audit and compensation committees. With the addition of Mr. Kaye, there will be seven members on the Dyadic Board.
Mr. Kaye currently the Chairman of the Audit Committee of Keryx Biopharmaceuticals, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.11% | 48.53M | |
| +33.37% | 50.85B | |
| +1.55% | 42.82B | |
| +49.17% | 42.03B | |
| -4.22% | 29.55B | |
| +11.57% | 26.11B | |
| -21.00% | 19.13B | |
| +7.36% | 13.05B | |
| +28.30% | 12.16B | |
| +23.80% | 12.08B |
DYADIC INTERNATIONAL, INC. 
